NECTIN4‐targeted antibody–drug conjugate is a potential therapeutic option for extramammary Paget disease
Yuka Tanaka(Kyushu University), Takeshi Nakahara(Kyushu University)
Cited by 7
Related Papers
Metformin inhibits IL-1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis
|Cell Death Discovery|2020|88
Role of ERK Pathway in the Pathogenesis of Atopic Dermatitis and Its Potential as a Therapeutic Target
|International Journal of Molecular Sciences|2022|36
Nectin Cell Adhesion Molecule 4 (NECTIN4) Expression in Cutaneous Squamous Cell Carcinoma: A New Therapeutic Target?
|Biomedicines|2021|33
Baicalein Inhibits Benzo[a]pyrene-Induced Toxic Response by Downregulating Src Phosphorylation and by Upregulating NRF2-HMOX1 System
|Antioxidants|2020|28
Human epidermal growth factor receptor 3 serves as a novel therapeutic target for acral melanoma
|Cell Death Discovery|2023|15